Skip Nav Destination
Issues
1 December 2018
-
Cover Image
Cover Image
Primary liver cancer (hepatocellular carcinoma, HCC) is on the rise in the United States, where it continues to increase in both incidence and death rate. Since there is no effective treatment for HCC, it is important to understand how whole foods rich in phytochemicals and natural chemicals found in plants, can protect against the development of HCC. In the current study, the chemopreventive effects of dietary tomato powder rich in lycopene was investigated in a diethylnitrosamine initiated and high fat diet-promoted HCC mouse model. The cover shows the histological section of a HCC from the liver of a male mice (H&E staining) in the absence of lycopene cleavage enzymes. The tomato powder feeding significantly decreased HCC incidence, multiplicity, and tumor volume independent of lycopene cleavage enzymes. The protection provided by tomato powder feeding was associated with the inhibition of inflammatory cytokines, inductions of hepatic sirtuin 1 deacetylase and circadian clock genes and improved gut microbial richness and diversity. The present study provides new insights into the mechanisms underlying the beneficial effect of tomato and tomato products against cancer development. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Commentary
AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health
Scott M. Lippman; Cory Abate-Shen; Karen L. Colbert Maresso; Graham A. Colditz; Andrew J. Dannenberg; Nancy E. Davidson; Mary L. Disis; Raymond N. DuBois; Eva Szabo; Anna R. Giuliano; William N. Hait; J. Jack Lee; Thomas W. Kensler; Barnett S. Kramer; Paul Limburg; Anirban Maitra; Maria Elena Martinez; Timothy R. Rebbeck; Kathryn H. Schmitz; Eduardo Vilar; Ernest T. Hawk
Research Articles
Dietary Tomato Powder Inhibits High-Fat Diet–Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes
Hui Xia; Chun Liu; Cheng-Chung Li; Maobin Fu; Shingo Takahashi; Kang-Quan Hu; Koichi Aizawa; Suganuma Hiroyuki; Guojun Wu; Liping Zhao; Xiang-Dong Wang
Author Choice
Evidence for Chemopreventive and Resilience Activity of Licorice: Glycyrrhiza Glabra and G. Inflata Extracts Modulate Estrogen Metabolism in ACI Rats
Shuai Wang; Tareisha L. Dunlap; Lingyi Huang; Yang Liu; Charlotte Simmler; Daniel D. Lantvit; Jenna Crosby; Caitlin E. Howell; Huali Dong; Shao-Nong Chen; Guido F. Pauli; Richard B. van Breemen; Birgit M. Dietz; Judy L. Bolton
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.